An Tran‐Duy

1.2k total citations
45 papers, 764 citations indexed

About

An Tran‐Duy is a scholar working on Economics and Econometrics, Rheumatology and Surgery. According to data from OpenAlex, An Tran‐Duy has authored 45 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Economics and Econometrics, 9 papers in Rheumatology and 8 papers in Surgery. Recurrent topics in An Tran‐Duy's work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Spondyloarthritis Studies and Treatments (5 papers). An Tran‐Duy is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (10 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Spondyloarthritis Studies and Treatments (5 papers). An Tran‐Duy collaborates with scholars based in Australia, Netherlands and United Kingdom. An Tran‐Duy's co-authors include Anne A. van Dam, J.W. Schrama, Arno W. Hoes, Coen D.A. Stehouwer, J.A.J. Verreth, Niek J. de Wit, Bart Spaetgens, Philip Clarke, Ben Smit and Annelies Boonen and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Diabetes Care.

In The Last Decade

An Tran‐Duy

39 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
An Tran‐Duy Australia 15 210 198 148 117 108 45 764
Victoria Price Canada 17 102 0.5× 6 0.0× 35 0.2× 76 0.6× 49 0.5× 50 909
William Anderson United States 15 68 0.3× 17 0.1× 57 0.4× 214 1.8× 5 0.0× 54 770
Jan Störmer Norway 17 279 1.3× 80 0.4× 73 0.5× 67 0.6× 1 0.0× 29 1.1k
Kyungil Park South Korea 16 159 0.8× 58 0.3× 63 0.4× 80 0.7× 68 720
J. P. Baker Canada 15 171 0.8× 45 0.2× 44 0.3× 40 0.3× 41 0.4× 22 759
Vadim Goz United States 22 854 4.1× 10 0.1× 22 0.1× 28 0.2× 2 0.0× 42 1.3k
Jukka Laitinen Finland 15 458 2.2× 17 0.1× 7 0.0× 330 2.8× 259 2.4× 26 886
Yanhong Li China 14 65 0.3× 25 0.1× 66 0.4× 44 0.4× 66 634
Caixia Liu China 14 61 0.3× 83 0.4× 55 0.4× 42 0.4× 2 0.0× 43 702

Countries citing papers authored by An Tran‐Duy

Since Specialization
Citations

This map shows the geographic impact of An Tran‐Duy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Tran‐Duy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Tran‐Duy more than expected).

Fields of papers citing papers by An Tran‐Duy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An Tran‐Duy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Tran‐Duy. The network helps show where An Tran‐Duy may publish in the future.

Co-authorship network of co-authors of An Tran‐Duy

This figure shows the co-authorship network connecting the top 25 collaborators of An Tran‐Duy. A scholar is included among the top collaborators of An Tran‐Duy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An Tran‐Duy. An Tran‐Duy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holmes‐Truscott, Elizabeth, Joanne M. Jordan, Leonid Churilov, et al.. (2025). Accelerating diabetes innovation for real‐world community impact through interdisciplinary research: Who is at the table?. Diabetic Medicine. 42(7). e70057–e70057.
2.
Sarker, Abdur Razzaque, et al.. (2025). Out-of-pocket cost and financial catastrophe of patients with cancer: the alarming cost-of-illness in Bangladesh. International Journal for Equity in Health. 24(1). 186–186. 2 indexed citations
3.
Tran‐Duy, An, et al.. (2024). Recovering from COVID-19 (ReCOV): Feasibility of an Allied-Health-Led Multidisciplinary Outpatient Rehabilitation Service for People with Long COVID. International Journal of Environmental Research and Public Health. 21(7). 958–958. 2 indexed citations
4.
James, Steven, et al.. (2024). Health‐related quality of life assessment in health economic analyses involving type 2 diabetes. Diabetic Medicine. 41(10). e15418–e15418.
5.
Darvall, Jai N., Anurika De Silva, Britta S. von Ungern‐Sternberg, et al.. (2024). Chewing Gum to Treat Postoperative Nausea and Vomiting in Female Patients: A Multicenter Randomized Trial. Anesthesiology. 142(3). 454–464. 3 indexed citations
6.
Mulhern, Brendan, Tianxin Pan, Richard Norman, et al.. (2023). Understanding the measurement relationship between EQ-5D-5L, PROMIS-29 and PROPr. Quality of Life Research. 32(11). 3147–3160. 3 indexed citations
7.
Summers, Matthew J., Lee‐anne S. Chapple, Rinaldo Bellomo, et al.. (2023). Study protocol for TARGET protein: The effect of augmented administration of enteral protein to critically ill adults on clinical outcomes: A cluster randomised, cross-sectional, double cross-over, clinical trial. Critical Care and Resuscitation. 25(3). 147–154. 10 indexed citations
8.
9.
Tran‐Duy, An, Josh Knight, Philip Clarke, et al.. (2021). Development of a life expectancy table for individuals with type 1 diabetes. Diabetologia. 64(10). 2228–2236. 14 indexed citations
10.
Pan, Tianxin, Brendan Mulhern, Rosalie Viney, et al.. (2021). Evidence on the relationship between PROMIS-29 and EQ-5D: a literature review. Quality of Life Research. 31(1). 79–89. 11 indexed citations
11.
Tran‐Duy, An, et al.. (2020). Measuring the economic impact of hospital-acquired complications on an acute health service. Australian Health Review. 45(2). 135–142. 15 indexed citations
12.
Tran‐Duy, An, Josh Knight, Andrew Palmer, et al.. (2020). A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes. Diabetes Care. 43(8). 1741–1749. 23 indexed citations
13.
Carvalho, Natalie, et al.. (2020). Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes in Patients With Rheumatoid Arthritis. The Journal of Rheumatology. 48(8). 1221–1229. 5 indexed citations
14.
15.
Darvall, Jai N., Britta S. von Ungern‐Sternberg, Sabine Braat, et al.. (2019). Chewing gum to treat postoperative nausea and emesis in female patients (CHEWY): rationale and design for a multicentre randomised trial. BMJ Open. 9(6). e027505–e027505. 6 indexed citations
16.
Tran‐Duy, An, Martijn A. H. Oude Voshaar, Harald E. Vonkeman, et al.. (2018). An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity. Arthritis & Rheumatology. 70(10). 1557–1564. 17 indexed citations
17.
Tran‐Duy, An, Bart Spaetgens, Arno W. Hoes, Niek J. de Wit, & Coen D.A. Stehouwer. (2016). Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 14(12). 1706–1719.e5. 145 indexed citations
18.
Severens, Johan L., et al.. (2014). How to Select the Right Cost-Effectiveness Model?. PharmacoEconomics. 32(5). 429–442. 7 indexed citations
19.
Tran‐Duy, An, Annelies Boonen, Wietske Kievit, et al.. (2014). Modelling Outcomes of Complex Treatment Strategies Following a Clinical Guideline for Treatment Decisions in Patients with Rheumatoid Arthritis. PharmacoEconomics. 32(10). 1015–1028. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victoria Price Breakdown of academic impact, for papers by William Anderson Breakdown of academic impact, for papers by Jan Störmer Breakdown of academic impact, for papers by Kyungil Park Breakdown of academic impact, for papers by J. P. Baker Breakdown of academic impact, for papers by Vadim Goz Breakdown of academic impact, for papers by Jukka Laitinen Breakdown of academic impact, for papers by Yanhong Li Breakdown of academic impact, for papers by Caixia Liu
Rankless by CCL
2026